Table 1.

Serum ALT, AST and ALB in each group (means ± SD)

Group	n	ALT(IU/L)	AST(IU/L)	ALB(g/L)
Control	10	22.3 ± 2.9	31.4 ± 4.8	32.4 ± 2.2
CCl4	15	121.7 ± 30.0 #	67.6 ± 14.6 #	29.3 ± 1.8 #
CCl4 + Sorafenib	10	73.8 ± 16.7#*	52.6 ± 8.7#*	31.6 ± 1.2
CCl4 + YGJ	10	77.9 ± 14.5#*	52.8 ± 9.5#*	32.6 ± 3.2*
CCl4 + iYGJ	10	72.6 ± 12.8#*	44.5 ± 8.8#*	32.7 ± 1.3*

Note: #, compared to control group P < 0.05; *, compared to CCl₄ group, P < 0.05